Inhibition of DNA synthesis and chromosome aberrations in cultured ehrlich ascites tumor cells following treatment with luteoskyrin.
D000818:Animals; D000880:Anthraquinones / Q000494:pharmacology*; D000963:Antimetabolites / Q000494:pharmacology*; D002247:Carbon Isotopes; D002273:Carcinogens / Q000494:pharmacology; D002286:Carcinoma, Ehrlich Tumor / Q000235:genetics / Q000378:metabolism*; D002869:Chromosome Aberrations; D046508:Culture Techniques; D004273:DNA, Neoplasm / Q000096:biosynthesis*; D007930:Leucine / Q000378:metabolism; D008055:Lipids / Q000032:analysis; D009183:Mycotoxins / Q000494:pharmacology*; D009363:Neoplasm Proteins / Q000096:biosynthesis; D010407:Penicillium / Q000032:analysis; D012334:RNA, Neoplasm / Q000096:biosynthesis; D013194:Staining and Labeling; D013936:Thymidine / Q000378:metabolism; D014529:Uridine / Q000378:metabolism
D000880:Anthraquinones; D000963:Antimetabolites; D002247:Carbon Isotopes; D002273:Carcinogens; D004273:DNA, Neoplasm; D008055:Lipids; D009183:Mycotoxins; D009363:Neoplasm Proteins; D012334:RNA, Neoplasm; D007930:Leucine; D013936:Thymidine; D014529:Uridine